Spirometry in rehabilitation of severe COVID-19 patients- a randomised controlled trial

Phase 2

• Conditions: Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

• Registration Number: CTRI/2021/08/035736
• Lead Sponsor: Dr Animesh Ray

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

a) Aged at least 18 years

b) Hospitalised

c) Confirmed SARS-CoV-2 infection by nucleic acid based testing (RT-PCR, CB-NAAT, or TrueNAT) or antigen testing

d) Moderate and severe COVID-19 pneumonia (SpO2 <94%)

e) Decreasing supplemental oxygen requirements (Nasal prongs <=6 L/min)

f) Hemodynamically stable

g) Cooperative

h) No medical history that might, in the opinion of the attending clinician, put the patient at significant risk if he/she were to participate in the trial

Exclusion Criteria

a) MMSE <24

b) Recent surgery, cardiovascular event (ACS, PE)

c) Moderate-severe heart disease (NYHA grade III or IV)

d) CLD with ascites

e) Prior history of TB, COPD, asthma, ILD

f) Pregnant and lactating women

g) Difficulty in mobilisation (for 6MWT)

h) Hemodynamically unstable

i) Refusal of consent

Study & Design

• Study Type: Interventional
• Study Design: Not specified